1. Home
  2. SGHC vs KYMR Comparison

SGHC vs KYMR Comparison

Compare SGHC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SGHC

Super Group (SGHC) Limited

N/A

Current Price

$10.86

Market Cap

5.4B

ML Signal

N/A

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

N/A

Current Price

$82.62

Market Cap

6.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SGHC
KYMR
Founded
2020
2015
Country
Guernsey
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.8B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
SGHC
KYMR
Price
$10.86
$82.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
26
Target Price
$17.33
$108.04
AVG Volume (30 Days)
3.1M
710.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.76%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$39,211,000.00
Revenue This Year
$29.10
$16.05
Revenue Next Year
$14.20
$4.79
P/E Ratio
$20.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.59
$19.45
52 Week High
$14.38
$103.00

Technical Indicators

Market Signals
Indicator
SGHC
KYMR
Relative Strength Index (RSI) 56.92 47.15
Support Level $10.59 $77.78
Resistance Level $11.93 $95.90
Average True Range (ATR) 0.55 4.43
MACD 0.06 -1.09
Stochastic Oscillator 60.36 14.60

Price Performance

Historical Comparison
SGHC
KYMR

About SGHC Super Group (SGHC) Limited

Super Group (SGHC) Ltd is a holding company that operates online sports betting and gaming businesses. The company's reportable segments are Betway, Spin, and Other. A majority of its revenue is generated from the Betway segment, which is a single-brand online sports betting and casino offering with licenses to operate throughout Europe, the Americas, and Africa. Spin is the company's multi-brand online casino offering, having a diverse portfolio of casino brands such as Jackpot City, Spin Casino, Dream Bingo, Mirror Bingo, etc., designed to be culturally relevant globally while aiming to offer a wide range of casino products. Geographically, the company generates maximum revenue from Africa and Middle East, followed by North America, Europe, Asia-Pacific, and South/Latin America.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: